Clinical Trials Directory

Trials / Unknown

UnknownNCT01623960

Quality of Life in Adult Patients With Severe Haemophilia in Turkey

A Nationwide Multicenter Study on the Quality of Life in Adult Patients With Severe Haemophilia in Turkey

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Turkish Society of Hematology · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this study is to evaluate the overall quality of life in adult patients with severe haemophilia (an inherited bleeding disorder affecting mainly men) in Turkey and to assess the impact of certain disease and drug related factors (treatment modality, presence of viral disease, inhibitor, etc.) on the quality of life.

Detailed description

Haemophilia is an inherited bleeding disorder affecting one in 10000 male births worldwide. People with severe haemophilia usually suffer from recurrent life threatening bleeds (e.g. into the brain, digestive system or abdomen) and/or disabling degenerative disease of weight bearing joints (e.g. knees, elbows and ankles)resulting from haemorrhage into the joints. Daily activities of people with haemophilia has been shown to be dramatically hampered by the resultant joint damage. Evaluation of quality of life issues in people with severe haemophilia would help to create awareness of their problems and limitations. This would also set up the scene for developing policies to improve the treatment options/facilities and social life of the patients. Current study aims to assess the quality of life of adult patients with severe haemophilia in a developing country (Turkey) by using a validated Quality of Life Questionnaire (Turkish version of Haem-A-QoL).

Conditions

Timeline

Start date
2012-10-01
Primary completion
2013-10-01
Completion
2014-02-01
First posted
2012-06-20
Last updated
2012-06-20

Source: ClinicalTrials.gov record NCT01623960. Inclusion in this directory is not an endorsement.